Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
bioinnovation capital
biolabs
biotech
boston
boston blog main
chemotherapy
contributors
daraprim
drug pricing
drugs
epipen
epipens
exome
gene therapy
generic drugs
insulin
johannes fruehauf
labcentral
life science
life sciences
martin shkreli
mylan
national xcon
novartis
oncology
peter kolchinsky
price collusion
spinal muscular atrophy
the biotech social contract
turin pharmaceuticals
zolgensma
What
healthcare
long
2
×
medical
wide
2
×
biotech
blueprint
complete
contributed
decades
demand
driving
drug
entered
factors
genetics
genome
good
health
history
human
improved
increased
industry
innovation
innovations
investment
key
life
millennium
nearly
new
outcomes
personalization
pricing
project
proud
public
research
sciences
sought
Language
unset
Current search:
wide
×
long
×
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@thenextweb.com
6 years ago
Why personalization is the key to long-term health
